secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001104659-26-032697
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio receives Nasdaq deficiency notice for bid price below $1.00
--------------------------------------------------------------------

- Nasdaq notified TELA on March 17, 2026 that bid price closed below $1.00 for 30 consecutive business days.
- Company has until September 14, 2026 to regain compliance by closing at $1.00 for 10 consecutive days.
- Stock continues trading on Nasdaq Global Market under symbol TELA; no immediate delisting effect.
- If not cured by September 14, TELA may transfer to Nasdaq Capital Market for a second 180-day cure period.
- Company says it will monitor bid price and consider options to regain compliance; no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926032697/0001104659-26-032697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926032697/tm269374d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-032697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer